Search Results

With a four-year, $3.3 million grant from the National Institutes of Health (NIH), researchers from Case Western Reserve University will study whether certain brain proteins may play a role in development of Alzheimer's disease. (Representational image: Pixabay)
Medicine

Researchers Close in on Understanding Possible Cause of Alzheimer’s Disease

MBT Desk
2 min read
National Institutes of Health (NIH)-backed study will examine the potential function of epitope (Eph) receptors in Alzheimer’s disease
New research suggests outdoor light pollution at night may be a significant risk factor for Alzheimer’s disease, especially in individuals under 65. (Representational Image: Wikimedia Commons)
Fitness and Wellness

Study Suggests Outdoor Light at Night May Be Linked to Increased Risk of Alzheimer’s Disease

Ankur Deka
3 min read
New research highlights a potential connection between nighttime light exposure and Alzheimer's disease, particularly among younger individuals
Neurologists diagnose cognitive impairment through clinical exams of memory and thinking skills. To confirm Alzheimer's disease, evidence of specific brain changes is needed, usually obtained via brain scans or spinal taps. (Representational Image: Unsplash)
Medicine

Accuracy of Diagnostic Blood Tests for Alzheimer’s Disease Varies

MBT Desk
4 min read
Varying Accuracy of Diagnostic Blood Tests for Alzheimer's Disease
In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognitive functions in mice with symptoms of Alzheimer’s disease by effectively jumpstarting the brain's memory circuitry. (Representational image: Pixabay)
Biotechnology

Molecule Restores Cognition, Memory in Alzheimer’s Disease Model Mice

MBT Desk
4 min read
A molecule identified and synthesized by UCLA Health researchers was shown to restore cognitive functions.
The FDA approved a new Alzheimer’s disease treatment today called donanemab (brand name Kisunla), after it was reviewed and recommended by an advisory panel earlier this year. (Representational Image: Pixabay)
Biotechnology

Expert Available: FDA Approval of Alzheimer's Disease Drug, Donanemab

MBT Desk
2 min read
The FDA approved a new Alzheimer’s disease treatment called donanemab (brand name Kisunla), after it was reviewed and recommended by an advisory panel earlier this year.
Alzheimer's disease often presents a complex journey, not only for the individual diagnosed but also for their caregivers.
Medicine

Managing Behavioral Changes in Middle Stages of Alzheimer's Disease

MBT Desk
3 min read
Alzheimer's disease often presents a complex journey, not only for the individual diagnosed but also for their caregivers.
Read More
logo
Medbound
www.medboundtimes.com